EUVIMEDEUVIMED entdecken
Crossref

Quality of life in patients who underwent low-dose-rate brachytherapy for prostate cancer with 10-year follow-up

Yasushi Nakai, Kenta Onishi, Isao Asakawa, Makito Miyake, Kaori Yamaki, Fumiaki Isohashi, Akihiko Yoshizawa, Kiyohide Fujimoto, Nobumichi Tanaka

Brachytherapy · 2026

DOI: 10.1016/j.brachy.2026.07.164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brachytherapy, 2026. Verfasst von Yasushi Nakai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nara Medical University, Nara, Japan; Department of Prostate Brachytherapy, Nara Medical University, Nara, Japan. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Brachytherapy, Quality of Life. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To evaluate the long-term follow-up quality of life (QOL) outcomes in patients who underwent low-dose-rate brachytherapy (LDR-BT) for prostate cancer. METHODS AND MATERIALS: Between May 2010 and January 2018, 853 patients who completed Expanded Prostate Cancer Index Composite (EPIC) questionnaires before treatment were enrolled in the present study. QOL was evaluated before treatments, at 1, 3, 6, 12, 24, 36, 48, 60, and 120 months after LDR-BT. Factors related to satisfaction with LDR-BT were evaluated using binary logistic regression analysis. RESULTS: At 1, 3, 6, 12, 24, 36, 48, 60 and 120 months after LDR-BT, 553/852 (65%), 570/840 (68%), 609/847 (72%), 677/837 (81%), 645/814 (79%), 636/789 (81%), 656/767 (86%), 626/730 (86%), and 282/330 (85%) patients were satisfied with the treatment. At 24, 60, and 120 months after LDR-BT, maintained QOL in the urinary (Odds ratio (OR): 0.43, 95% confidence interval (CI): 0.29-0.61) and bowel (OR: 0.61, 95% CI 0.43-0.87) domains, maintained QOL in the urinary (OR: 0.30, 95% CI 0.20-0.47), bowel (OR: 0.53, 95% CI 0.35-0.82), and hormonal domains (OR: 0.44, 95% CI 0.28-0.70), and biochemical recurrence-free within 5 years after LDR-BT (OR: 0.16, 95% CI 0.07-0.39), and maintained QOL in the bowel (OR: 0.43, 95% CI 0.23-0.81) domain were significantly related to satisfaction with LDR-BT for prostate cancer, respectively. CONCLUSIONS: Maintained urinary, bowel, and hormonal QOL and biochemical control were related to satisfaction with LDR-BT for prostate cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBrachytherapyQuality of LifeHumansMaleFollow-Up StudiesAgedMiddle AgedRadiotherapy DosagePatient SatisfactionSurveys and QuestionnairesAged, 80 and overTreatment Outcome

Stichwörter der Autor:innen

BrachytherapyPatient satisfactionProstate cancerQuality of lifeRadiotherapy

Autor:innen und Institutionen

  • Department of Urology, Nara Medical University, Nara, Japan; Department of Prostate Brachytherapy, Nara Medical University, Nara, Japan.
  • Department of Urology, Nara Medical University, Nara, Japan.
  • Department of Prostate Brachytherapy, Nara Medical University, Nara, Japan; Department of Radiation Oncology, Nara Medical University, Nara, Japan.
  • Department of Radiation Oncology, Nara Medical University, Nara, Japan.
  • Department of Diagnostic Pathology, Nara Medical University, Nara, Japan.
  • Department of Urology, Nara Medical University, Nara, Japan; Department of Prostate Brachytherapy, Nara Medical University, Nara, Japan. Electronic address: sendo@naramed-u.ac.jp.

Zitieren

APA

Nakai, Y., Onishi, K., Asakawa, I., Miyake, M., Yamaki, K., Isohashi, F., Yoshizawa, A., Fujimoto, K., & Tanaka, N. (2026). Quality of life in patients who underwent low-dose-rate brachytherapy for prostate cancer with 10-year follow-up. Brachytherapy. https://doi.org/10.1016/j.brachy.2026.07.164

Vancouver

Nakai Y, Onishi K, Asakawa I, Miyake M, Yamaki K, Isohashi F, et al. Quality of life in patients who underwent low-dose-rate brachytherapy for prostate cancer with 10-year follow-up. Brachytherapy. 2026. doi:10.1016/j.brachy.2026.07.164

BibTeX
@article{Nakai2026,
  author = {Nakai, Yasushi and Onishi, Kenta and Asakawa, Isao and Miyake, Makito and Yamaki, Kaori and Isohashi, Fumiaki and Yoshizawa, Akihiko and Fujimoto, Kiyohide and Tanaka, Nobumichi},
  title = {Quality of life in patients who underwent low-dose-rate brachytherapy for prostate cancer with 10-year follow-up},
  journal = {Brachytherapy},
  year = {2026},
  doi = {10.1016/j.brachy.2026.07.164}
}
Kostenlos starten →